In a seminal study, Collins et al. [25] showed that, in patients with hypoparathyroidism or pseudohypoparathyroidism, calcitriol therapy not only elevates serum vitamin D levels, but also increases serum FGF-23 levels. The gene discussed is FGF23; the disease is hypoparathyroidism.